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General practice
Prevalence and clinical characteristics of left ventricular
dysfunction among elderly patients in general practice
setting: cross sectional survey
S Morgan, H Smith, I Simpson, G S Liddiard, H Raphael, R M Pickering, D Mant
Abstract
Objective To assess the prevalence and clinical
characteristics of left ventricular dysfunction among
elderly patients in the general practice setting by
echocardiographic assessment of ventricular function.
Design Cross sectional survey.
Setting Four centre general practice in Poole, Dorset.
Subjects 817 elderly patients aged 70›84 years.
Main outcomes Echocardiographic assessment of left
ventricular systolic function including measurement
of ejection fraction by biplane summation method
where possible, clinical symptoms, and signs of left
ventricular dysfunction.
Results The overall prevalence of left ventricular
systolic dysfunction was 7.5% (95% confidence
interval 5.8% to 9.5%); mild dysfunction (5.0%) was
considerably more prevalent than moderate (1.6%) or
severe dysfunction (0.7%). Measurement of ejection
fraction was possible in 82% of patients (n = 667): in
patients categorised as having mild, moderate, or
severe dysfunction, the mean ejection fraction was
48% (SD 12.0), 38% (8.1), and 26% (7.9) respectively.
At all ages the prevalence was much higher in men
than in women (odds ratio 5.1, 95% confidence
interval 2.6 to 10.1). No clinical symptom or sign was
both sensitive and specific. In around half the patients
with ventricular dysfunction (52%, 32/61) heart
failure had not been previously diagnosed.
Conclusions Unrecognised left ventricular
dysfunction is a common problem in elderly patients
in the general practice setting. Appropriate treatment
with angiotensin converting enzyme inhibitors has the
potential to reduce hospitalisation and mortality in
these patients, but diagnosis should not be based on
clinical history and examination alone. Screening is
feasible in general practice, but it should not be
implemented until the optimum method of
identifying left ventricular dysfunction is clarified, and
the cost effectiveness of screening has been shown.
Introduction
Heart failure is a common cause of hospitalisation and
death across the industrialised world. In contrast to
coronary artery disease and stroke, the number of hos›
pital admissions and deaths attributed to heart failure
is increasing, and this rise is predicted to continue.1–4
Improving the diagnosis and care of patients with
heart failure is therefore likely to have a major impact
on morbidity, mortality, and healthcare costs, which in
the United Kingdom are estimated to be £360 million
a year.5
Systolic left ventricular dysfunction, which can be
observed by echocardiography, is the commonest
cause of the clinical syndrome of heart failure. Clinical
trials have shown that treatment, particularly with
angiotensin converting enzyme inhibitors, can increase
survival and improve quality of life for patients with
severe, moderate, and mild systolic left ventricular
dysfunction.6–9 The substantial protective effect of treat›
ment on mortality and hospitalisation has been shown
in a meta analysis (odds ratio 0.65, 95% confidence
interval 0.57 to 0.74).10 Progression to overt clinical
heart failure can also be delayed by treatment of
asymptomatic left ventricular dysfunction.11
The ability to develop a coherent strategy to apply
the evidence in a community setting is limited by a lack
of knowledge about the extent, severity, and age distri›
bution of left ventricular systolic dysfunction in the
general population.12 The prevalence of clinical heart
failure has been reported from Framingham13 and
elsewhere,14 but knowledge of the prevalence of left
ventricular systolic dysfunction, as determined by
echocardiography, in the United Kingdom is limited to
one cross sectional survey in Glasgow of patients aged
25›74 years.15 This survey was restricted to responders
to the 1992 monitoring trends and determinants in
cardiovascular disease risk factor survey and included
few patients from elderly age groups, who contribute
most to the overall burden of heart failure. Our study
aimed to determine the prevalence of left ventricular
systolic dysfunction, as detected by echocardiography,
in patients from an unselected general practice
population aged over 70 years.
Subjects and methods
Sample
We selected a random sample of 1200 individuals aged
70›84 years from the age›sex register of a large four
centre group general practice in Poole, Dorset. Of
these patients, we excluded 144 (12.0%) as they had
died or were no longer registered with the practice.
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The remaining 1056 patients were invited to attend for
clinical and echocardiographic examination. House›
bound patients were offered a home assessment. In
total, 817 (77.4%) patients received an echocardio›
graphic assessment. The mean age of those assessed
was 76.1 years (SD 3.9 years), and 442 (54.1%) of them
were women. Patients who declined assessment were
slightly older (mean 77.0 years, SD 4.2, P = 0.004) and
more likely to be women (62.0%, P = 0.03).
The study was approved by the local research ethics
committee.
Clinical assessment
We collected data on 12 clinical symptoms and signs
that are commonly considered by clinicians in primary
care in the diagnosis of heart failure. The symptoms
were breathlessness at rest, when walking, when trying
to sleep, and at any time in the previous two weeks. The
signs were tachycardia ( > 90 beats/min), third heart
sound, gallop rhythm, raised jugular venous pressure
( > 5 cm), hepatomegaly, hepatojugular reflux, basal
crepitations, and bilateral ankle oedema. Patients who
attended the surgery were seen in sequence by the
study doctor, echocardiography technician, and nurse.
Patients unable to attend were offered the same assess›
ment at home. The blood pressure recorded was the
mean of two readings taken with the patient rested and
sitting, using an automatic sphygmomanometer
(UA›751, A and D Medical, Tokyo).
Echocardiography
A detailed echocardiographic examination was per›
formed by an experienced senior cardiac technician
without reference to the clinical findings of the doctor,
using a Sonos 100 CF (Hewlett Packard, MS, USA)
cardiovascular imaging system providing two dimen›
sional echocardiography, spectral Doppler and colour
Doppler flow mapping information using a 2.5 or
3.5 MHz duplex transducer and a 1.9 MHz sound only
continuous wave Doppler transducer. Standard views
were obtained with the patient in the left lateral
position. Images were stored on videotape. Two
dimensional, M mode, colour flow, and Doppler studies
were performed on all patients. Left ventricular
function was assessed qualitatively as normal, mild,
moderate, or severe dysfunction. Where possible, we
calculated the ejection fraction by the biplane disc
summation method (Simpson’s rule).16
The final decision on grading of ventricular
dysfunction was made by a senior cardiologist (IS). The
assessment was achieved by reanalysis of videotape
recordings of patients who were found by the
technician to have any degree of left ventricular
dysfunction, with the first results concealed. Normal
left ventricular function was reported if there was no
more than one dysfunctional echocardiographic
segment of the left ventricular myocardium. Mild
global left ventricular hypokinesis was regarded as
normal in the presence of â blockers or other
negatively inotropic agents. In three patients the
videotape recording was inadequate, and in a further
eight patients a videotape was not available because
they had been assessed at home. In these cases, classifi›
cation was based on the judgment of the technician
who had conducted the initial examination.
We maintained continuous quality assurance by
asking a sample of around 5% of patients (weighted by
abnormality) to attend for rescreening at the local hos›
pital. Results were given continually to the practice
based technician. As a further quality control measure,
we interspersed videotaped recordings of a random
sample of 23 patients who had normal ventricular
function with the abnormal tapes reanalysed by the
cardiologist, without any means of distinguishing
them. All patients were confirmed as normal.
Review of medical records
We reviewed the computerised and paper records,
including hospital correspondence, for all patients with
echocardiographic evidence of left ventricular dysfunc›
tion. Any record of a previous diagnosis of ventricular
dysfunction or heart failure by a general practitioner or
hospital cardiologist, an echocardiogram report of
heart failure or left ventricular dysfunction, or a chest x
ray report of heart failure or increased cardiothoracic
ratio were accepted as evidence of a previous diagnosis
of heart failure.
Statistical analysis
We carried out statistical analysis using Stata.17 We used
the ÷2 test to compare categorical variables, and two
sample t tests for quantitative variables. We calculated
95% confidence intervals using the binomial exact
method for binary variables, and we estimated odds
ratios using the Mantel Haenzsel method and logistic
regression. We developed a multivariate model using
forward selection with an entry criterion of P<0.05
using a likelihood ratio test (see table 4). We developed
the model presented in table 5 using factors from the
clinical history and examination detected in five or
more patients. These were included initially in a back›
ward stepwise logistic regression model using a signifi›
cance level of < 0.1 for entry and > 0.2 for removal.
These criteria enabled more of the clinical factors to be
included and their predictive power presented. The
inclusion of age and sex in this model altered the odds
ratio for the clinical variables only slightly, and the odds
ratios presented in table 5 are not adjusted for these
variables.
Results
Table 1 shows the prevalence of left ventricular systolic
dysfunction in men and women. Prevalence was
significantly higher in men than in women (12.8% ver›
sus 2.9%; P < 0.001). Mild dysfunction was considerably
more prevalent (5.0%) than moderate dysfunction
(1.6%) or severe dysfunction (0.7%). It was possible to
make a measurement of ejection fraction in 667
patients (82%). The mean ejection fraction for normal,
mild, moderate, and severe categories was 66.3% (SD
13.5), 47.7% (12.0), 38.3% (8.1), and 26.0% (7.9) based
on measurement in 624, 29, 9, and 5 patients
respectively.
Table 2 shows the prevalence of any grade of
dysfunction by age and sex. The overall prevalence of
all grades of dysfunction was 7.5% (95% confidence
interval 5.8% to 9.5%). Prevalence was more than twice
as high at age >80 than at ages 70›74, but the relative
difference between men and women was preserved
(20.5% versus 5.4%; P < 0.05).
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Tables 3 and 4 show the characteristics that predict
left ventricular dysfunction and that might therefore be
used as criteria for selective screening in general prac›
tice. Reassuringly, the strongest predictor in the multi›
variate model presented in table 4 was a previous
diagnosis of heart failure (adjusted odds ratio 5.8, 95%
confidence interval 2.9 to 11.5) followed by male sex
(5.1, 2.6 to 10.1). A previous diagnosis of vascular
disease (stroke, myocardial infarction, or angina) was
also associated with around a twofold increase in risk
of left ventricular dysfunction. The overall increase in
risk with age was around 10% per year. Smoking
history showed no significant association with echocar›
diographic findings. About half (48%, 29/61) of all
patients with left ventricular dysfunction had previous
heart failure documented in their medical records:
83% (5/6) in patients with severe dysfunction
compared with 34% (14/41) in patients with mild dys›
function.
Table 5 shows the clinical variables, including
medical history, that independently predicted left ven›
tricular dysfunction. The strongest predictors were his›
tory of myocardial infarction (odds ratio 3.8; positive
likelihood ratio 4.3) and angina (2.6; 3.3). The most
specific physical sign was a raised jugular venous pres›
sure > 5 cm (specificity 97%, 95% confidence interval
95% to 98%). The most sensitive physical sign was basal
crepitations (sensitivity 44%, 32% to 56%). Hepato›
megaly (n = 3), hepatojugular reflux (n = 3), and gallop
rhythm (n = 2) did not show significant univariate
association with left ventricular dysfunction. A third
heart sound was detected in only one patient; this
patient did have left ventricular dysfunction. If those
patients with left ventricular dysfunction who had pre›
viously been diagnosed with heart failure were
excluded from the analysis, then none of the clinical
examination variables contributed to the model of
independent predictors of left ventricular dysfunction.
Of the patients who on examination had one of the
factors included in the multivariate model, only
between one seventh and one quarter of them had
abnormal left ventricular function on echocardio›
graphic examination.
The proportion of those patients with left ventricu›
lar dysfunction who had been prescribed treatment
with diuretics was 36% (22/61), with angiotensin
converting enzyme inhibitors was 33% (20/61), and
with digoxin was 16% (10/61).
Discussion
Left ventricular systolic dysfunction is common in eld›
erly patients in general practice. About 1 in 20 patients
aged 70›74 and 1 in 10 patients aged 75›84 have left
ventricular dysfunction. There are no comparable data
for patients aged over 75 years, but for patients aged
65›74 years our estimate is consistent with the
Table 1 Prevalence of echocardiographically graded left ventricular function by sex
Left ventricular function
Men (n=375) Women (n=442)
No Prevalence (%) (95% CI) No Prevalence (%) (95% CI)
Normal 327 87.2 (83.3 to 90.4) 429 97.1 (95.0 to 98.4)
Mild dysfunction 31 8.3 (5.7 to 11.5) 10 2.3 (1.1 to 4.1)
Moderate dysfunction 11 2.9 (1.5 to 5.2) 3 0.7 (0.1 to 2.0)
Severe dysfunction 6 1.6 (0.6 to 3.4) 0 0 (0 to 0.8)*
*One sided 97.5% confidence interval.
Table 2 Age specific prevalence of abnormal left ventricular function*
Age group
(years)
Men Women Men and women combined
No Prevalence (%) (95% CI) No Prevalence (%) (95% CI) No Prevalence (%) (95% CI)
All ages 48/375 12.8 (9.6 to 16.6) 13/442 2.9 (1.8 to 5.0) 61/817 7.5 (5.8 to 9.5)
70›74 17/180 9.4 (5.5 to 14.7) 4/184 2.2 (0.6 to 5.5) 21/364 5.8 (3.6 to 8.7)
75›79 16/122 13.1 (7.7 to 20.4) 4/166 2.4 (0.7 to 6.1) 20/288 6.94 (4.3 to 10.5)
80›84 15/73 20.5 (12.0 to 31.6) 5/92 5.4 (1.8 to 12.2) 20/165 12.1 (7.6 to 18.1)
*Abnormal includes mild, moderate, and severe dysfunction.
Table 3 Risk factors for any grade of left ventricular dysfunction by univariate analysis
with Mantel Haenzsel odds ratios adjusted for age and sex (n=817)
Risk factor
% (No) of patients
Odds ratio
(95% CI) P value
With left ventricular
dysfunction (n=61)
With no left ventricular
dysfunction (n=756)
Male 79 (48) 43 (327) 5.0* (2.6 to 9.6) <0.001
Never smoked 21 (13) 35 (268) 1 (baseline) —
Former smoker 72 (44) 55 (418) 1.3 (0.7 to 2.4) 0.430
Current smoker 7 (4) 9 (70) 0.8 (0.2 to 2.3) 0.620
Age group (years)
70›74 34 (21) 45 (343) 1 (baseline) —
75›79 33 (20) 35 (268) 1.4† (0.7 to 2.6) 0.339
80›84 33 (20) 19 (145) 2.5† (1.3 to 4.9) 0.005
Self reported history
Any heart disease 80 (49) 50 (377) 4.1 (2.1 to 8.0) <0.001
Hypertension‡ 41 (25) 35 (263) 1.4 (0.8 to 2.5) 0.207
Angina 48 (29) 16 (119) 4.3 (2.5 to 7.6) <0.001
Myocardial infarction 39 (24) 9 (70) 4.9 (2.7 to 9.0) <0.001
Heart failure 34 (21) 6 (45) 7.3 (3.8 to 14) <0.001
Stroke 15 (9) 4 (33) 3.1 (1.3 to 7.5) 0.006
Diabetes 10 (6) 6 (43) 1.7 (0.7 to 4.5) 0.258
*Age adjusted only.
†Sex adjusted only.
‡Including clinical measurement of blood pressure (systolic >160 mmHg or diastolic >90 mmHg) reduced
odds ratio to 1.0 (95% confidence interval 0.6 to 1.8).
Table 4 Odds ratio of having any grade of echocardiographically abnormal left
ventricular function from multivariate logistic regression model (n=816)
Variable Odds ratio (95% CI) P value
Male 5.1 (2.6 to 10.1) <0.001
Age (per year) 1.1 (1.0 to 1.2) 0.028
Heart failure* 5.8 (2.9 to 11.5) <0.001
Myocardial infarction* 2.6 (1.3 to 5.2) 0.007
Stroke* 2.6 (1.1 to 6.4) 0.034
Angina* 2.1 (1.1 to 4.2) 0.031
*History reported by subject of these conditions at any age.
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estimated prevalence of ventricular dysfunction of
5.6% reported from a Glasgow study (Glasgow has a
substantially higher standardised mortality ratio for
cardiovascular disease, but the sample assessed was
limited to a selected population of responders to a
questionnaire).15 The prevalence of ventricular dys›
function in a smaller sample from Rotterdam, aged
>70 years, was considerably lower at 4.2%.18 Patient
selection and a lower response rate could account for
the low prevalence in this Dutch population, which was
described as relatively healthy.
A key finding of our study is the higher prevalence
of disease in men than in women. This is consistent
with gender differences in the prevalence of ischaemic
heart disease, but runs contrary to the general practice
stereotype of an elderly breathless woman with swollen
legs. Interestingly, previous prevalence estimates in the
United Kingdom, which have relied on review of gen›
eral practice records based on assessment of clinical
features, electrocardiograms, and chest x rays,19 20 have
shown no apparent gender difference in prevalence in
elderly age groups. This may reflect the difficulty of
making a reliable diagnosis of heart failure without
echocardiography, particularly in patients who may
have peripheral oedema and breathlessness for a vari›
ety of non›cardiac causes.21
At the design stage of our study we agreed that
prevalence should be reported on the basis of
categorical grading of global left ventricular systolic
function rather than quantitative measurement of ejec›
tion fraction. This decision was made partly in the
knowledge of the difficulty of making reliable measure›
ments of ejection fraction in this age group (especially
in subjects most likely to have abnormal left ventricular
function), and partly because we anticipated that global
assessment was likely to be the best predictor of
outcome and benefit from treatment in elderly
patients. Without longer follow up we lack data to jus›
tify the assertion that global assessment is likely to be
the best predictor of outcome and benefit from
treatment in elderly patients, but the clear separation
and gradient of mean ejection fraction for each
category indicates that qualitative categorisation and
quantitative assessment of ejection fraction are broadly
consistent with each other.22 The number of abnormal
echocardiograms not reviewed by the cardiologist was
small, and thus even if all were false positive diagnoses
these would only have inflated the prevalence by 1.3%.
The high response rate, the use of home
assessment, and the similar demographic characteris›
tics of responders and non›responders encourages us
to believe that our prevalence estimates are robust. It
seems unlikely that the lower assessment rate among
women can account for more than a small part of the
observed gender difference. Our study was, however,
set in a desirable retirement area, which is likely to have
had inward migration of more affluent and possibly fit›
ter elderly people. Thus our prevalence estimate may
be lower than in less privileged areas and may
underestimate the prevalence of left ventricular
dysfunction in the United Kingdom.
Only half of our patients with left ventricular
dysfunction had a previous record of heart failure in
their medical records. This was confirmed by the
observed levels of prescribing of diuretics and angio›
tensin converting enzyme inhibitors. There are a
substantial number of elderly individuals who have
asymptomatic or misdiagnosed left ventricular dysfunc›
tion, which is likely to be due to the very limited sensitiv›
ity and specificity of clinical history taking and
examination in general practice. Only 11% of patients
with left ventricular dysfunction will have a raised jugu›
lar venous pressure. Bilateral ankle oedema has the
unfortunate characteristic of relatively high prevalence
in the general population and relatively low specificity.
Although these clinical findings are useful in acute
severe heart failure at the time of hospitalisation, they
have only a small role in detecting left ventricular
dysfunction in the community.23 24 Our study extends
and explains the findings of Remes, that the clinical
diagnosis of left ventricular dysfunction in primary care
is not accurate or easy.21 Clinical diagnosis based on
raised jugular venous pressure, bilateral ankle oedema,
or basal crepitations will very often be misleading.
On the evidence of our study, targeting individuals
for more detailed assessment on the basis of gender,
age, and a history of ischaemic heart disease would
detect a substantial proportion of the currently unrec›
ognised left ventricular dysfunction. However, it would
be unwise to embark on a screening programme in
elderly people (whether or not selected by age, sex, or
medical history) until we have better evidence of its
cost effectiveness in this elderly patient group.
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Table 5 Clinical factors that independently predict left ventricular dysfunction, and their
sensitivity, specificity, and positive likelihood ratio
Variable
Odds ratio*
(95% CI)
Sensitivity
(%) Specificity (%)
Positive
likelihood ratio
History
Breathlessness when walking 2.3 (0.9 to 6.4) 15 (9/60) 97 (730/751) 5.4
Examination
Jugular venous pressure >5 cm 2.4 (0.8 to 6.8) 11 (7/61) 97 (721/745) 3.6
Basal crepitations 2.4 (1.3 to 4.3) 44 (6/61) 82 (727/751) 2.4
Bilateral peripheral oedema 1.9 (0.9 to 4.1) 18 (11/61) 91 (684/751) 2.0
Past history
Myocardial infarction 3.8 (1.9 to 7.4) 39 (24/61) 91 (686/756) 4.3
Angina 2.6 (1.4 to 5.0) 48 (29/61) 84 (637/756) 3.3
*Adjusted for other factors by multivariate analysis (see text).
Key messages
x Left ventricular dysfunction detected by
echocardiography is common in elderly people
x Men are much more likely to be affected than
women
x The accuracy of clinical diagnosis is very limited
in this age group
x Many patients who would benefit from
treatment remain undetected
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Patients’ perceptions of medical explanations for
somatisation disorders: qualitative analysis
Peter Salmon, Sarah Peters, Ian Stanley
Abstract
Objectives To describe, from the perspective of
patients, distinguishing features of doctors’ attempts
to explain the symptoms of somatisation disorders.
Design Qualitative analysis of verbatim records of
interviews in which patients recounted doctors’
explanations of their symptoms.
Setting Patients with persistent somatising symptoms
referred from general practices in Liverpool and St
Helens and Knowsley were interviewed before entry
into a treatment programme.
Subjects 228 of 324 patients referred were
interviewed. Initial interviews were used to develop
the process and technique, and the final analysis was
based on a subsample of 68 records, randomly chosen
from the transcripts of 188 subjects who were
interviewed subsequently.
Results Doctors’ explanations were often at odds with
the patients’ own thinking. Analysis showed that
medical explanations could be grouped into one of
three categories, defined by the patients’ perceptions.
Most explanations were experienced as rejecting the
reality of the symptoms. An intermediate category
comprised explanations that were viewed as colluding,
in which the doctor acquiesced with the patients’ own
biomedical theories. However, a few explanations
were perceived by patients as tangible, exculpating,
and involving. These explanations were experienced
by patients as satisfying and empowering.
Conclusions Patients with somatisation disorders feel
satisfied and empowered by medical explanations that
are tangible, exculpating, and involving. Empowering
explanations could improve these patients’ wellbeing
and help to reduce the high demands they make on
health services.
Introduction
The nomenclature of disease has been developed to
facilitate communication between doctors and other
healthcare professionals. It is not designed to provide
explanations for patients, and may occasionally be
used to obscure their understanding.1 Recent emphasis
on doctors’ communication skills reflects not only
mounting pressure from patients who want infor›
mation so that they can participate in their own care2
but also the profession’s wish to uphold its traditional
responsibility of translating its language and thinking
into terms that can be understood by lay people.3 4
Lay beliefs about illness form a parallel but much
less well recognised explanatory system reflecting
cultural, social, and political influences—for example,
from the media or the activities of pressure groups.5 6
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